INmune Bio Inc. has listed on the Nasdaq stock exchange and is actively pursuing patent applications for its CORDStrom platform, with operations spanning Europe and Latin America.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
INmune Bio Inc. has listed on the Nasdaq stock exchange and is actively pursuing patent applications for its CORDStrom platform, with operations spanning Europe and Latin America.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United States Patent and Trademark Office
agency in the United States Department of Commerce